Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06507930 | RECRUITING | Breast Cancer

The COMPASSION Study
Sponsor:

Dana-Farber Cancer Institute

Information provided by (Responsible Party):

Claire Smith

Brief Summary:

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.

Condition or disease

Breast Cancer

Metastatic Breast Cancer

Advanced Breast Cancer

Unresectable Breast Carcinoma

Intervention/treatment

Telehealth Hospice Visits

Phase

NA

Detailed Description:

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams. Study procedures include giving verbal consent to participate and a one-time survey delivered by email or phone call. About 200 people, which includes 50 participants, 50 caregivers, 50 hospice nurses, and about 50 oncology providers, are expected to participate in this research study.

Study Type : INTERVENTIONAL
Estimated Enrollment : 200 participants
Masking : NONE
Primary Purpose : HEALTH_SERVICES_RESEARCH
Official Title : The COMPASSION Study: Applying Telehealth to Innovate and Strengthen Connections for Patients With Metastatic Breast Cancer Receiving Hospice Care
Actual Study Start Date : 2024-09-01
Estimated Primary Completion Date : 2025-09-01
Estimated Study Completion Date : 2026-03-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Patient of any gender with unresectable locally advanced or metastatic breast cancer
  • * Eligible for in-home hospice services and referred by DFCI clinical team to in-home hospice \
  • * Ability to conduct video or phone check-ins, even if assistance required.
  • * Able to provide verbal consent with a willingness to take a survey at 4-6 weeks, if medically able
  • * Hospice setting is within Massachusetts
  • * Non-English language allowed but interpreter services must be present at each meeting and will be coordinated by scheduling team
  • * Willingness to provide a caregiver/loved one's contact information for survey contact at 4 weeks after enrollment
Exclusion Criteria
  • * Unable to provide verbal consent
  • * Hospice care planned outside of a home setting (note: if participants start out in a home hospice setting but later transition their hospice care to an inpatient setting, enrollment is allowed as long as they started in a home setting)
  • * Hospice setting outside of Massachusetts
  • * Individuals who are under the age of 18, as this is not a project focused on pediatric patients.
The COMPASSION Study

Location Details

NCT06507930

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, Massachusetts

Dana-Farber Cancer Institute

Boston, Massachusetts, United States, 02215